These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 25366341)
1. Adverse reactions to radiopharmaceuticals in France: analysis of the national pharmacovigilance database. Laroche ML; Quelven I; Mazère J; Merle L Ann Pharmacother; 2015 Jan; 49(1):39-47. PubMed ID: 25366341 [TBL] [Abstract][Full Text] [Related]
2. Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis. Kunac DL; Tatley MV Drug Saf; 2011 Jan; 34(1):59-71. PubMed ID: 21142271 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of Radiopharmaceutical Adverse Reaction Reports to the British Nuclear Medicine Society from 2007 to 2016. Kennedy-Dixon TG; Gossell-Williams M; Cooper M; Trabelsi M; Vinjamuri S J Nucl Med; 2017 Dec; 58(12):2010-2012. PubMed ID: 28522742 [TBL] [Abstract][Full Text] [Related]
4. Neonatal adverse drug reactions: an analysis of reports to the French pharmacovigilance database. Kaguelidou F; Beau-Salinas F; Jonville-Bera AP; Jacqz-Aigrain E Br J Clin Pharmacol; 2016 Oct; 82(4):1058-68. PubMed ID: 27276109 [TBL] [Abstract][Full Text] [Related]
5. Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase. Kröger E; Mouls M; Wilchesky M; Berkers M; Carmichael PH; van Marum R; Souverein P; Egberts T; Laroche ML Ann Pharmacother; 2015 Nov; 49(11):1197-206. PubMed ID: 26324356 [TBL] [Abstract][Full Text] [Related]
7. Full report on a survey of adverse reactions to radiopharmaceuticals from 1975 to 2017 in Japan. Matsuda H; Uehara T; Okazawa H; Mizumura S; Yokoyama K; Yoshimura M; Ann Nucl Med; 2020 Apr; 34(4):299-304. PubMed ID: 31989466 [TBL] [Abstract][Full Text] [Related]
8. Systematic review of paediatric studies of adverse drug reactions from pharmacovigilance databases. Cliff-Eribo KO; Sammons H; Choonara I Expert Opin Drug Saf; 2016 Oct; 15(10):1321-8. PubMed ID: 27501085 [TBL] [Abstract][Full Text] [Related]
9. [Adverse drug reactions in pediatrics: Experience of a regional pharmacovigilance center]. Saint-Martin C; Kanagaratnam L; de Boissieu P; Azzouz B; Abou Taam M; Trenque T Therapie; 2016 Oct; 71(5):467-473. PubMed ID: 27203165 [TBL] [Abstract][Full Text] [Related]
10. Serious central nervous system side effects of cephalosporins: A national analysis of serious reports registered in the French Pharmacovigilance Database. Lacroix C; Kheloufi F; Montastruc F; Bennis Y; Pizzoglio V; Micallef J J Neurol Sci; 2019 Mar; 398():196-201. PubMed ID: 30683462 [TBL] [Abstract][Full Text] [Related]
11. Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001). Thiessard F; Roux E; Miremont-Salamé G; Fourrier-Réglat A; Haramburu F; Tubert-Bitter P; Bégaud B Drug Saf; 2005; 28(8):731-40. PubMed ID: 16048358 [TBL] [Abstract][Full Text] [Related]
12. Adverse drug reactions to self-medication: a study in a pharmacovigilance database. Berreni A; Montastruc F; Bondon-Guitton E; Rousseau V; Abadie D; Durrieu G; Chebane L; Giroud JP; Bagheri H; Montastruc JL Fundam Clin Pharmacol; 2015 Oct; 29(5):517-20. PubMed ID: 26215671 [TBL] [Abstract][Full Text] [Related]
13. Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France. Auffret M; Labreuche J; Duhamel A; Deheul S; Cottencin O; Bordet R; Gautier S; Rolland B Drug Saf; 2017 Mar; 40(3):257-262. PubMed ID: 27988884 [TBL] [Abstract][Full Text] [Related]
14. Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug-drug interactions: a PharmacoVigilance study in France. Danton AC; Montastruc F; Sommet A; Durrieu G; Bagheri H; Bondon-Guitton E; Lapeyre-Mestre M; Montastruc JL Eur J Clin Pharmacol; 2013 Apr; 69(4):885-8. PubMed ID: 22996074 [TBL] [Abstract][Full Text] [Related]
15. Drug-induced adverse reactions via breastfeeding: a descriptive study in the French Pharmacovigilance Database. Soussan C; Gouraud A; Portolan G; Jean-Pastor MJ; Pecriaux C; Montastruc JL; Damase-Michel C; Lacroix I Eur J Clin Pharmacol; 2014 Nov; 70(11):1361-6. PubMed ID: 25183382 [TBL] [Abstract][Full Text] [Related]
16. Bevacizumab-induced serious side-effects: a review of the French pharmacovigilance database. Taugourdeau-Raymond S; Rouby F; Default A; Jean-Pastor MJ; Eur J Clin Pharmacol; 2012 Jul; 68(7):1103-7. PubMed ID: 22349162 [TBL] [Abstract][Full Text] [Related]
17. Frequency and Nature of Adverse Drug Reactions Due to Non-Prescription Drugs in Children: A Retrospective Analysis from the French Pharmacovigilance Database. Durrieu G; Maupiler M; Rousseau V; Chebane L; Montastruc F; Bondon-Guitton E; Montastruc JL Paediatr Drugs; 2018 Feb; 20(1):81-87. PubMed ID: 28766184 [TBL] [Abstract][Full Text] [Related]
18. Impact of the COVID-19 outbreak on the reporting of adverse drug reactions associated with self-medication. Gras M; Gras-Champel V; Moragny J; Delaunay P; Laugier D; Masmoudi K; Liabeuf S Ann Pharm Fr; 2021 Sep; 79(5):522-529. PubMed ID: 33631179 [TBL] [Abstract][Full Text] [Related]
19. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal. Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533 [TBL] [Abstract][Full Text] [Related]
20. Safety profile of etifoxine: A French pharmacovigilance survey. Cottin J; Gouraud A; Jean-Pastor MJ; Dautriche AD; Boulay C; Geniaux H; Auffret M; Bernard N; Descotes J; Vial T Fundam Clin Pharmacol; 2016 Apr; 30(2):147-52. PubMed ID: 26588183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]